Matches in SemOpenAlex for { <https://semopenalex.org/work/W2047032012> ?p ?o ?g. }
- W2047032012 endingPage "125" @default.
- W2047032012 startingPage "125" @default.
- W2047032012 abstract "Ouabain inhibits monocyte activation in vitro: prevention of the proinflammatory mCD14+/CD16+ subset appearance and cell-size progression Raphael C Valente,1 Elizabeth G Araujo,2 Vivian M Rumjanek11Instituto de Bioquímica Médica, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil; 2Departamento de Neurobiologia, Universidade Federal Fluminense, Rio de Janeiro, BrazilAbstract: Classically described as a potent inhibitor of the sodium-potassium adenosine triphosphatase enzyme, ouabain has been further shown to act as an effective immunomodulator in mammals. Recently, our group showed that this hormone downregulates membrane CD14 (mCD14) in human monocytes, though it is not known whether monocyte activation status could modify ouabain influence. Hence, we aimed to investigate ouabain effect during monocyte activation in vitro, analyzing mCD14, CD16 and CD69 expression in total monocytes after two periods of adhesion (2 hours and 24 hours) or in small and large monocyte subpopulations separately. Ouabain (100 nM) inhibited monocyte-size increase, characteristic of activation, only when added to cells immediately after 2 hours' adhesion. Moreover, downregulation of both mCD14 and CD16 expression by ouabain was more effective in small monocytes and in cells after 2 hours' adhesion. Since monocytes after 24 hours' adhesion showed no lack of ouabain binding and no CD69 upregulation, it seems that ouabain is somehow incapable of triggering an appropriate cell-signaling induction once monocytes become activated. Furthermore, though p38 MAPK activation was crucial for the impairment in cell-size progression induced by ouabain, its inhibition did not alter ouabain-induced CD69 upregulation, suggesting that other molecules may participate in the response to this hormone by monocytes. Our data suggest that ouabain inhibits monocyte activation in vitro, preventing both cell-size increase and the appearance of the proinflammatory mCD14+/CD16+ subpopulation. Thus, the findings suggest that individuals suffering from disorders commonly associated with high ouabain plasma levels, like hypertension, may present defective monocyte activation under inflammation or infection.Keywords: ouabain, human monocytes, p38 MAPK, mCD14, CD16, CD69" @default.
- W2047032012 created "2016-06-24" @default.
- W2047032012 creator A5069195198 @default.
- W2047032012 creator A5085966780 @default.
- W2047032012 creator A5091357005 @default.
- W2047032012 date "2012-10-01" @default.
- W2047032012 modified "2023-09-27" @default.
- W2047032012 title "Ouabain inhibits monocyte activation in vitro: prevention of the proinflammatory mCD14+/CD16+ subset appearance and cell-size progression" @default.
- W2047032012 cites W101740868 @default.
- W2047032012 cites W1684019827 @default.
- W2047032012 cites W1781555612 @default.
- W2047032012 cites W1942388374 @default.
- W2047032012 cites W1966809056 @default.
- W2047032012 cites W1974146012 @default.
- W2047032012 cites W1977502961 @default.
- W2047032012 cites W1983419107 @default.
- W2047032012 cites W1984687894 @default.
- W2047032012 cites W1988340848 @default.
- W2047032012 cites W1988641862 @default.
- W2047032012 cites W1989243684 @default.
- W2047032012 cites W1993064155 @default.
- W2047032012 cites W1994190235 @default.
- W2047032012 cites W2000793858 @default.
- W2047032012 cites W2007087804 @default.
- W2047032012 cites W2009429943 @default.
- W2047032012 cites W2013980575 @default.
- W2047032012 cites W2015955199 @default.
- W2047032012 cites W2022977288 @default.
- W2047032012 cites W2041042099 @default.
- W2047032012 cites W2041849710 @default.
- W2047032012 cites W2042820283 @default.
- W2047032012 cites W2045384882 @default.
- W2047032012 cites W2047802705 @default.
- W2047032012 cites W2048621856 @default.
- W2047032012 cites W2049727721 @default.
- W2047032012 cites W2056066719 @default.
- W2047032012 cites W2060198845 @default.
- W2047032012 cites W2060402183 @default.
- W2047032012 cites W2061422374 @default.
- W2047032012 cites W2064395270 @default.
- W2047032012 cites W2069354590 @default.
- W2047032012 cites W2073940975 @default.
- W2047032012 cites W2081644104 @default.
- W2047032012 cites W2086128996 @default.
- W2047032012 cites W2086595476 @default.
- W2047032012 cites W2089821558 @default.
- W2047032012 cites W2093443561 @default.
- W2047032012 cites W2097814316 @default.
- W2047032012 cites W2098593412 @default.
- W2047032012 cites W2112117215 @default.
- W2047032012 cites W2116153685 @default.
- W2047032012 cites W2116947619 @default.
- W2047032012 cites W2122508595 @default.
- W2047032012 cites W2136786880 @default.
- W2047032012 cites W2137798077 @default.
- W2047032012 cites W2138064921 @default.
- W2047032012 cites W2150594596 @default.
- W2047032012 cites W2158345511 @default.
- W2047032012 cites W2164030289 @default.
- W2047032012 cites W2166704273 @default.
- W2047032012 cites W2341730211 @default.
- W2047032012 cites W2442542770 @default.
- W2047032012 cites W4211217677 @default.
- W2047032012 cites W76529961 @default.
- W2047032012 doi "https://doi.org/10.2147/jep.s35507" @default.
- W2047032012 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4863552" @default.
- W2047032012 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27186125" @default.
- W2047032012 hasPublicationYear "2012" @default.
- W2047032012 type Work @default.
- W2047032012 sameAs 2047032012 @default.
- W2047032012 citedByCount "1" @default.
- W2047032012 countsByYear W20470320122014 @default.
- W2047032012 crossrefType "journal-article" @default.
- W2047032012 hasAuthorship W2047032012A5069195198 @default.
- W2047032012 hasAuthorship W2047032012A5085966780 @default.
- W2047032012 hasAuthorship W2047032012A5091357005 @default.
- W2047032012 hasBestOaLocation W20470320121 @default.
- W2047032012 hasConcept C104317684 @default.
- W2047032012 hasConcept C114684123 @default.
- W2047032012 hasConcept C127561419 @default.
- W2047032012 hasConcept C134018914 @default.
- W2047032012 hasConcept C1491633281 @default.
- W2047032012 hasConcept C164027704 @default.
- W2047032012 hasConcept C167672396 @default.
- W2047032012 hasConcept C178790620 @default.
- W2047032012 hasConcept C185592680 @default.
- W2047032012 hasConcept C203014093 @default.
- W2047032012 hasConcept C2776914184 @default.
- W2047032012 hasConcept C2778513237 @default.
- W2047032012 hasConcept C2779133857 @default.
- W2047032012 hasConcept C2781184567 @default.
- W2047032012 hasConcept C2781462264 @default.
- W2047032012 hasConcept C537181965 @default.
- W2047032012 hasConcept C553184892 @default.
- W2047032012 hasConcept C55493867 @default.
- W2047032012 hasConcept C85789140 @default.
- W2047032012 hasConcept C86803240 @default.
- W2047032012 hasConcept C8891405 @default.